- $4.55bn
- $5.11bn
- $3.79bn
FTI Consulting Q1 revenue growth beats estimates; outlook reaffirmed
Brief: FTI Consulting To Keep Steve Gunby As CEO After Dropping Succession Plan- FT
Brief: FTI Consulting Incremental Amendment Provides For $300 Million Term Loan - SEC Filing
RCS - Redx Pharma Limited - RXC008 Receives US FDA Fast Track Designation
RCS - Scotch Corner Dsgnr. - Intention to Float
FTI Consulting Q4 revenue up 11%, beats expectations
Media: Group of banks said to hire FTI as adviser for Raizen talks - Bloomberg News
Brief: Cybersecurity Expert Jason Smolanoff Joins Fti Consulting As A Senior Managing Director
Brief: FTI Consulting Expands Transactions Communications Capabilities With Two Senior Hires
RCS - Redx Pharma Limited - US FDA lifts Partial Clinical Hold on Zelasudil
FTI Consulting beats Q3 revenue estimates, raises FY forecast
RCS - Redx Pharma Limited - Redx new data show zelasudil well-tolerated in IPF
Launch of Intermediaries Offer
Apax Partners LLP Apax Global Alpha Ld - Prevailing Market Exchange Rate
RCS - Redx Pharma Limited - Redx Pharma to present new Phase 2a data at ERS
Brief: Fti Consulting Appoints Paul Linton As Interim CFO - SEC Filing
Brief: FTI Consulting Names Shaun Rangappa Chief Clinical Executive and Senior MD
Brief: Spirit Airlines Engages Advisers To Explore Repeat Restructuring- WSJ
Hong Kong's CKI emerges as leading contender for Thames Water, The Times reports (updated)